Wedge Capital Management L L P NC Takes Position in Teleflex Incorporated $TFX

Wedge Capital Management L L P NC bought a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 220,082 shares of the medical technology company’s stock, valued at approximately $26,929,000. Wedge Capital Management L L P NC owned 0.50% of Teleflex at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. grew its holdings in Teleflex by 242.9% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 153 shares during the period. Brooklyn Investment Group lifted its position in shares of Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after buying an additional 150 shares in the last quarter. True Wealth Design LLC grew its stake in Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after acquiring an additional 310 shares during the period. Parallel Advisors LLC increased its holdings in Teleflex by 43.1% in the 2nd quarter. Parallel Advisors LLC now owns 455 shares of the medical technology company’s stock worth $54,000 after acquiring an additional 137 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in Teleflex by 30.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company’s stock worth $77,000 after acquiring an additional 129 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 2.2%

Shares of NYSE TFX opened at $121.73 on Friday. Teleflex Incorporated has a 12-month low of $102.58 and a 12-month high of $185.94. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The stock has a market cap of $5.38 billion, a PE ratio of -16.56, a P/E/G ratio of 1.45 and a beta of 0.95. The company has a 50-day moving average of $120.13 and a 200 day moving average of $121.03.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. The company had revenue of $892.90 million for the quarter, compared to analyst estimates of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The firm’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date was Friday, November 14th. Teleflex’s dividend payout ratio is presently -18.50%.

Analyst Ratings Changes

Several research firms have issued reports on TFX. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Tuesday, December 9th. Wells Fargo & Company upped their price target on shares of Teleflex from $114.00 to $139.00 and gave the stock an “equal weight” rating in a research report on Wednesday, December 10th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 15th. Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Finally, Truist Financial raised their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday. One research analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $142.43.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.